{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
How has been the historical performance of Nureca?
Nureca's historical performance has shown significant declines in net sales, operating profit, and profitability, with net sales dropping from 255.55 Cr in Mar'22 to 109.66 Cr in Mar'25, and operating profit turning negative by Mar'25. Despite slight increases in total assets and liabilities, the company has faced challenging financial conditions with negative cash flow from operating activities.
Nureca Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit
Nureca Ltd has witnessed extraordinary buying momentum, registering a strong 4.99% gain today with only buy orders in the queue, signalling a potential multi-day upper circuit scenario. This surge outpaces the broader Sensex, reflecting robust investor enthusiasm in the healthcare services sector.
Nureca Ltd Hits Upper Circuit Amid Strong Buying Pressure and Market Momentum
Nureca Ltd, a micro-cap player in the Healthcare Services sector, witnessed robust market activity as its stock hit the upper circuit price limit on 28 Nov 2025. The surge was driven by intense buying interest, resulting in a maximum daily gain of 4.97%, significantly outperforming its sector and broader market indices.
Why is Nureca falling/rising?
On 27 Nov, Nureca Ltd's stock price surged by 4.92% to close at ₹280.65, reflecting a notable rebound driven by robust quarterly earnings and increased promoter confidence, despite the company’s longer-term challenges and underperformance against benchmarks.
Nureca Stock Hits Upper Circuit Amid Strong Buying Pressure and Market Momentum
Nureca Ltd, a player in the healthcare services sector, witnessed its shares hit the upper circuit price limit on 27 Nov 2025, reflecting robust buying interest and a surge in market activity. The stock closed at ₹275.85, marking a daily gain of 4.99%, outperforming its sector and broader market indices amid heightened investor participation and a regulatory trading freeze.
Nureca Stock Hits Upper Circuit Amid Strong Buying Pressure
Shares of Nureca Ltd, a micro-cap player in the Healthcare Services sector, surged to hit the upper circuit limit on 26 Nov 2025, reflecting robust investor demand and a notable reversal after a week of declines. The stock closed at ₹262.75, marking a 5.0% gain on the day and outperforming its sector peers significantly.
Nureca Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit
Nureca Ltd has witnessed extraordinary buying momentum today, registering a sharp 4.98% gain and hitting an intraday high of Rs 267.5. The stock’s trading activity is marked by an absence of sellers, resulting in a rare upper circuit scenario that could extend over multiple sessions as demand continues to outstrip supply.
Why is Nureca falling/rising?
As of 18-Nov, Nureca Ltd's stock price is 266.00, down 1.92%, continuing a downward trend despite strong financial results and increased promoter confidence. The stock has underperformed against benchmarks and faces long-term fundamental weaknesses, contributing to investor caution.
How has been the historical performance of Nureca?
Nureca's historical performance has shown significant declines, with net sales dropping from 255.55 Cr in Mar'22 to 109.66 Cr in Mar'25, and operating profit turning negative with a loss of 7.54 Cr in Mar'25. The company has faced challenges in profitability and cash flow, with negative cash flow of 19.00 Cr in Mar'25 compared to a positive 34.00 Cr in Mar'21.
Nureca Adjusts Evaluation Score Amid Mixed Technical Indicators and Rising Promoter Confidence
Nureca, a microcap healthcare services company, has recently adjusted its evaluation score, reflecting a shift in technical trends. Despite a positive Q2 FY25-26 performance, the company faces long-term challenges with declining operating profits. Promoter confidence is rising, with an increased stake now at 64.97%.
Why is Nureca falling/rising?
As of 07-Nov, Nureca Ltd's stock price is Rs 283.95, up 4.99% with a three-day total return of 10.49%. Despite recent gains and outperforming its sector, there is a significant decline in investor participation, indicating potential volatility ahead.
Nureca Ltd Surges 4.99% Today, Achieves 22% Gain Over One Month Amid Market Decline
Nureca Ltd, a microcap in healthcare services, is experiencing notable buying activity, with a recent increase of 4.99%. Over the past week, the stock has risen by 7.99%, contrasting with a slight decline in the Sensex. Despite a one-year decline, Nureca's recent performance shows strong upward momentum.
Nureca Ltd Stock Hits Upper Circuit Limit with Intraday High of Rs 284.75
Nureca Ltd's stock reached an intraday high of Rs 284.75, hitting the upper circuit limit and reflecting strong performance. The company outperformed its sector and saw significant trading volume, despite a decline in delivery volume. This performance highlights Nureca's resilience and investor interest in a challenging market.
Nureca Ltd Stock Hits Upper Circuit Limit with Intraday High of Rs 271.2
Nureca Ltd, a microcap in healthcare services, reached its upper circuit limit today, achieving an intraday high of Rs 271.2. The stock has shown strong performance, trading above key moving averages and demonstrating resilience in a declining sector, with notable trading volume and turnover.
Nureca Ltd Stock Rises 4.91% Today, Reaching Intraday High of Rs 270.45 Amid Market Decline
Nureca Ltd, a microcap in healthcare services, is experiencing notable buying activity, with recent stock gains contrasting with a slight decline in the Sensex. Over the past month, Nureca's stock has appreciated significantly, despite a negative year-to-date performance compared to the broader market.
How has been the historical performance of Nureca?
Nureca's historical performance has been volatile, with net sales peaking at 255.55 Cr in Mar'22 and declining to 109.66 Cr by Mar'25, alongside increasing expenditures and negative operating profit since Mar'23. While profit after tax turned positive at 0.85 Cr in Mar'25, the company continues to face significant operational challenges.
Why is Nureca falling/rising?
As of 29-Oct, Nureca Ltd's stock price is Rs 261.80, down 9.16% and reflecting a significant decline of 17.93% over the past week. The stock has underperformed compared to the broader market, which has seen positive returns, indicating ongoing challenges for the company.
Why is Nureca falling/rising?
As of 24-Oct, Nureca Ltd's stock price is Rs 302.35, down 5.04% after three consecutive days of decline. Despite strong financial results, the stock's long-term fundamentals are weak, leading to decreased investor confidence and a cautious market sentiment.
Why is Nureca falling/rising?
As of 23-Oct, Nureca Ltd's stock price is at 318.40, down 0.19%, following a two-day decline of 5.5%. Despite strong short-term performance, recent drops in trading volume and consecutive losses indicate caution among investors.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
